Watkins Tim
CMO & Head of Development
CIK: 2065965
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Contineum Therapeutics, Inc. (CTNM) | S | 3,611 | $15.02 | $54,220.25 | View Details Filing |
| Mar 2, 2026 | Contineum Therapeutics, Inc. (CTNM) | M | 3,611 | $0.00 | $0.00 | View Details Filing |
| Mar 2, 2026 | Contineum Therapeutics, Inc. (CTNM) | M | 3,611 | $4.50 | $16,249.50 | View Details Filing |
| Jan 30, 2026 | Contineum Therapeutics, Inc. (CTNM) | A | 160,000 | $0.00 | $0.00 | View Details Filing |
| Jan 28, 2026 | Contineum Therapeutics, Inc. (CTNM) | S | 2,800 | $14.09 | $39,441.08 | View Details Filing |
| Jan 28, 2026 | Contineum Therapeutics, Inc. (CTNM) | M | 3,611 | $0.00 | $0.00 | View Details Filing |
| Jan 28, 2026 | Contineum Therapeutics, Inc. (CTNM) | S | 811 | $14.48 | $11,747.17 | View Details Filing |
| Jan 28, 2026 | Contineum Therapeutics, Inc. (CTNM) | M | 3,611 | $4.50 | $16,249.50 | View Details Filing |
| Dec 29, 2025 | Contineum Therapeutics, Inc. (CTNM) | M | 3,611 | $0.00 | $0.00 | View Details Filing |
| Dec 29, 2025 | Contineum Therapeutics, Inc. (CTNM) | M | 3,611 | $4.50 | $16,249.50 | View Details Filing |
| Dec 29, 2025 | Contineum Therapeutics, Inc. (CTNM) | S | 3,611 | $12.06 | $43,558.41 | View Details Filing |